<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta name="keywords" content="" />
<meta name="description" content="" />
<meta http-equiv="content-type" content="text/html; charset=utf-8" />
<title>Neural Picks - Free AI Powered Stock Market Advice</title>
<link href="//fonts.googleapis.com/css?family=Abel|Arvo" rel="stylesheet" type="text/css" />
<link href="style.css" rel="stylesheet" type="text/css" media="screen" />
</head>
<body>
<div id="wrapper">
<div id="header">
<div id="logo">
<h1><a href="#">neural picks</a></h1>
</div>
</div>
<div id="about">
<h2 class="title">Updated on: 05/03/2021, 20:40:18</h2>
<p><img src="images/pics01.jpg" alt="" width="225" height="225" class="alignleft" /><strong>Disclaimer:</strong> This is a project for fun and none of the stock recommendations here should be executed using real money. I am not a professional stock advisor. All trading decisions and associated risks are your own, and I do not take responsibility for any losses.<br /><br /><strong>About:</strong> Stocks are ranked using Deep Learning according to performance on different quantitative and qualitative metrics. Stocks higher up on the list are predicted to have the highest returns over the next 3 weeks, but daily price swings can vary significantly. Forming a portfolio of multiple stocks can reduce daily risks.<br /><br /><strong>Contribute:</strong> Our mission is to further democratize finance by organizing high-quality publicly available information into actionable rankings. This information is free, however donations are highly appreciated at SegWit Bitcoin Wallet Address: bc1qxv7drjce5hx9l6eyht6ejtx2rex36an78fp82t</p>
<!-- AddToAny BEGIN -->
<div class="a2a_kit a2a_kit_size_32 a2a_default_style">
<a class="a2a_dd" href="https://www.addtoany.com/share"></a>
<a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_reddit"></a>
</div>
<script async src="https://static.addtoany.com/menu/page.js"></script>
<!-- AddToAny END --></div>
<div id="page">
<div id="content"><div class="post"><h2 class="title"><a href="#">NVCR</a></h2><p class="meta">Rank #1 | $202.56 / share</p><div class="entry">       <p>NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. The company markets Optune and NovoTTF-100L, a Tumor Treating Fields delivery system for use as a monotherapy treatment for adult patients with glioblastoma. It is also developing products that are in Phase 2 pilot and Phase 3 pivotal trials for brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer, and mesothelioma. The company markets its products in the European Union, Japan, and internationally. It has a clinical trial collaboration agreement with MSD to evaluate tumor treating fields together with KEYTRUDA, an anti-PD-1 therapy; and a strategic alliance with the NYU Grossman School of Medicine's Department of Radiation Oncology that provides a framework for preclinical and clinical development projects studying Tumor Treating Fields. NovoCure Limited was founded in 2000 and is based in Saint Helier, Jersey.</p>       <ul>
       <li>Suggested By Multiple Sources</li>
       <li>Robinhood Adjusted Rating: 35.294%</li>
       <li>Financial Modeling Prep Rating: 50.0%</li>
       <li>Finnhub Adjusted Rating: 60.177%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Fair Stock Price Estimate: $204.83 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: -36.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">NVAX</a></h2><p class="meta">Rank #2 | $195.12 / share</p><div class="entry">       <p>Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company's lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate that in Phase III clinical trial to protect infants from RSV disease through maternal immunization; and NanoFlu, which is in Phase III clinical trial for treating seasonal influenza in older adults. Its lead adjuvant is Matrix-M that is used to enable a vaccine to enhance the amplitude of the immune response and qualitatively change it, and the immune systems attack against microorganisms, as well as to allow immunization with much lower doses of antigen. The company is also developing RSV F vaccine for older adults (60 years and older) that is in Phase II clinical trial, as well as for healthy children between six months to five years of age that is in Phase I clinical trial. In addition, it develops nanoparticle vaccine candidates for clinic testing against ebola virus that is in Phase I clinical trial; and combination respiratory vaccine to protect against influenza and RSV. Further, the company is developing COVID-19 vaccine for coronavirus that causes pneumonia-like symptoms, which is in preclinical stage. It has a partnership agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.</p>       <ul>
       <li>Financial Modeling Prep Rating: 0.0%</li>
       <li>Finnhub Adjusted Rating: 89.796%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 100.0%</li>
       <li>Social Media Sentiment: 78.176%</li>
       <li>Fair Stock Price Estimate: $204.74 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: -52.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">PLNT</a></h2><p class="meta">Rank #3 | $82.5 / share</p><div class="entry">       <p>Planet Fitness, Inc., together with its subsidiaries, franchises and operates fitness centers under the Planet Fitness name. It operates through three segments: Franchise, Corporate-Owned Stores, and Equipment. The Franchise segment is involved in franchising business in the United States, Puerto Rico, Canada, the Dominican Republic, Panama, Mexico, and Australia. The Corporate-Owned Stores segment operates corporate-owned stores in the United States and Canada. The Equipment segment engages in the sale of fitness equipment to franchisee-owned stores in the United States. As of December 31, 2019, the company had 2,001 stores, including 1,903 franchised and 98 corporate-owned stores in the District of Columbia, Puerto Rico, Canada, the Dominican Republic, Panama, Mexico, and Australia. Planet Fitness, Inc. was founded in 1992 and is headquartered in Hampton, New Hampshire.</p>       <ul>
       <li>Robinhood Adjusted Rating: 55.172%</li>
       <li>Financial Modeling Prep Rating: 0.0%</li>
       <li>Finnhub Adjusted Rating: 73.889%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Fair Stock Price Estimate: $87.8 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: 40.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">VICI</a></h2><p class="meta">Rank #4 | $32.05 / share</p><div class="entry">       <p>VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.</p>       <ul>
       <li>Robinhood Adjusted Rating: 91.892%</li>
       <li>Financial Modeling Prep Rating: 100.0%</li>
       <li>Finnhub Adjusted Rating: 93.827%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 79.46%</li>
       <li>Fair Stock Price Estimate: $20.02 (Stock is Overvalued)</li>
       <li>Insider Trading Transactions Rating: 44.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">IIPR</a></h2><p class="meta">Rank #5 | $178.69 / share</p><div class="entry">       <p>Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. Innovative Industrial Properties, Inc. has elected to be taxed as a real estate investment trust, commencing with the year ended December 31, 2017.</p>       <ul>
       <li>Financial Modeling Prep Rating: 50.0%</li>
       <li>Finnhub Adjusted Rating: 86.239%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 79.46%</li>
       <li>Social Media Sentiment: 24.489%</li>
       <li>Fair Stock Price Estimate: $190.54 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: 0.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">CPLP</a></h2><p class="meta">Rank #6 | $13.27 / share</p><div class="entry">       <p>Capital Product Partners L.P., a shipping company, provides marine transportation services in Greece. Its vessels transports a range of dry cargoes and containerized goods under short-term voyage charters, and medium to long-term time and bareboat charters. As of March 05, 2020, the company owned 14 vessels, including 13 Neo-Panamax container vessels and one capesize bulk carrier. Capital GP L.L.C. serves as the general partner of the company. The company was founded in 2007 and is headquartered in Piraeus, Greece.</p>       <ul>
       <li>Financial Modeling Prep Rating: 50.0%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Fair Stock Price Estimate: $16.46 (Stock is Undervalued)</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">EXTR</a></h2><p class="meta">Rank #7 | $11.34 / share</p><div class="entry">       <p>Extreme Networks, Inc. provides software-driven networking solutions for enterprise, data center, and service provider customers worldwide. It designs, develops, and manufactures wired and wireless network infrastructure equipment; and develops software for network management, policy, analytics, security, and access controls. The company offers ExtremeSwitching portfolio that includes access edge products that offer physical presentations along with options to deliver Ethernet or convergence-friendly Power-over-Ethernet (POE), including high-power universal POE; aggregation/core switches designed to address aggregation, top-of-rack, and campus core environments; and wireless access point products. It also provides ExtremeNAC, a network access control solution that allows the enterprises to unify the security of their wired and wireless networks with visibility and control over users, devices, and applications; and ExtremeAnalytics, a network-powered application analytics and optimization solution, which captures, aggregates, analyses, correlates, and reports network data that enables in decision making and enhancing business performance. In addition, the company offers ExtremeCloud, a wired and wireless cloud network management solution, which offers visibility and control over users, devices, and applications; ExtremeRouting, a cloud-managed access across distributed environment that provides throughput, application-aware traffic shaping and monitoring, end-to-end service, and link prioritization; and an open northbound API for customized integrations to key enterprise platforms. It markets and sells its products through distributors, resellers, and field sales organizations to enterprises and organizations in the education, healthcare, retail, manufacturing, hospitality, transportation and logistics, government agencies, private cloud data centers, universities, and stadiums. Extreme Networks, Inc. was founded in 1996 and is headquartered in San Jose, California.</p>       <ul>
       <li>Financial Modeling Prep Rating: 50.0%</li>
       <li>Finnhub Adjusted Rating: 77.273%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Fair Stock Price Estimate: $12.96 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: -36.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">GMAB</a></h2><p class="meta">Rank #8 | $36.24 / share</p><div class="entry">       <p>Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL). Its products under development include Ofatumumab to treat CLL and multiple sclerosis; Daratumumab to treat MM, natural killer/T-cell lymphoma, and amyloidosis; Tisotumab vedotin for treating cervical, ovarian, and solid cancers; HuMax-AXL-ADC, and HexaBody-DR5/DR5 for treating solid cancers; and DuoBody-CD3xCD20 for the treatment of B-cell malignancies. The company's products under development also comprise Teprotumumab for the treatment of Graves' orbitopathy; Camidanlumab tesirine (ADCT-301) to treat lymphoma, solid tumors, and acute myeloid leukemia (AML); HuMax-IL8 (BMS-986253) for treating advanced cancers; JNJ-61186372 for the treatment of non-small-cell lung cancer; JNJ-63709178 to treat AML; JNJ-64007957 and JNJ-64407564 for MM; and Lu AF82422 for treating Parkinson's disease. In addition, it has approximately 20 active pre-clinical programs, including naked, bispecific, and immune effector function enhanced antibodies. The company has a commercial license and collaboration agreement with Seattle Genetics, Inc. to co-develop tisotumab vedotin, an antibody-drug conjugate; and a strategic collaboration agreement with Tempus to advance various disease targets and biomarkers, as well as Rentschler Biopharma SE. It also has a collaboration agreement with Immatics Biotechnologies GmbH to research and develop next-generation bispecific immunotherapies for treating multiple cancer indications; CureVac AG for the research and development of differentiated mRNA-based antibody products; and Tavotek Biotherapeutics and AbbVie. Genmab A/S was founded in 1999 and is based in Copenhagen, Denmark.</p>       <ul>
       <li>Robinhood Adjusted Rating: 69.388%</li>
       <li>Financial Modeling Prep Rating: 50.0%</li>
       <li>Finnhub Adjusted Rating: 83.396%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">MBIN</a></h2><p class="meta">Rank #9 | $43.03 / share</p><div class="entry">       <p>Merchants Bancorp (Indiana) is a bank holding company, which specializes in a multiple lines of business in banking and finance. The company is headquartered in Carmel, Indiana and currently employs 259 full-time employees. The Bank operate multiple lines of business with a focus on FHA multi-family housing and healthcare facility financing and servicing, mortgage warehouse financing, retail and correspondent residential mortgage banking, agricultural lending and traditional community banking. The Bank operates in three primary segments: Multi-family Mortgage Banking, Mortgage Warehousing, and Banking. The Multi-family Mortgage Banking segment originates and services government sponsored mortgages for multi-family and healthcare facilities. The Mortgage Warehousing segment funds agency eligible residential loans from origination or purchase to sale in the secondary market, as well as commercial loans to non-depository financial institutions. The Banking segment provides a wide range of financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage and other consumer loan products.</p>       <ul>
       <li>Financial Modeling Prep Rating: 50.0%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Fair Stock Price Estimate: $49.29 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: 8.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">TREX</a></h2><p class="meta">Rank #10 | $108.45 / share</p><div class="entry">       <p>Trex Company, Inc. manufactures and distributes wood and plastic composite products, and related accessories for residential and commercial decking, and railing applications in the United States. It offers Trex Transcend, Trex Select, and Trex Enhance protective shells for protection against fading, staining, mold, and scratching; and Trex Hideaway, a hidden fastening system for grooved boards; and Trex DeckLighting, a LED dimmable deck lighting for use on posts, floors, and steps. The company also provides Trex Transcend Railing products used in Trex decking products and other decking materials; Trex Select Railing for simple clean finished look; Trex Enhance railing system; and Trex Signature aluminum railing for contemporary look. In addition, it offers Trex Seclusions fencing product, including structural posts, bottom and top rails, pickets, and decorative post caps; and Trex Elevations, a steel deck framing system. Further, the company acts as a licensor in various licensing agreements with third parties to manufacture and sell products under the Trex name, including Trex Outdoor Furniture; Trex RainEscape, an above joist deck drainage system; Trex CustomCurve that allows contractors to heat and bend Trex products; Trex Pergola, a cellular PVC product; Trex Latticeworks outdoor lattice boards; Trex Cornhole boards; Diablo Trex Blade, a saw blade for wood-plastic composite decking; Trex SpiralStairs and structural steel posts; Trex Outdoor Kitchens, Cabinetry, and Storage; and Trex Outdoor Fire & Water products. Additionally, it offers architectural and aluminum railing systems, and staging equipment and accessories. The company sells its products through wholesale distributors, retail lumber dealers, and Home Depot and Lowe's stores, as well as through its direct sales staff, independent sales representatives, and bidding on projects. The company was founded in 1996 and is headquartered in Winchester, Virginia.</p>       <ul>
       <li>Robinhood Adjusted Rating: 50.0%</li>
       <li>Financial Modeling Prep Rating: 50.0%</li>
       <li>Finnhub Adjusted Rating: 70.395%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Fair Stock Price Estimate: $109.5 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: -8.0%</li>
       </ul>
</div></div></div>
</div>
</div>
<div id="footer">
<p>&copy; Jonathan Davies. All rights reserved. Design by <a href="http://templated.co" rel="nofollow">TEMPLATED</a>.</p>
</div>
</body>
</html>